Alexander J Ohnmacht

Artificial intelligence in early drug discovery enabling precision medicine

M. Menden, D. Saur, B. Schubert, 2021, Expert opinion on drug discovery.

The pharmacoepigenomic landscape of cancer cell lines reveals the epigenetic component of drug sensitivity

Emanuel J. V. Gonçalves, M. Menden, D. Saur, 2023, Communications biology.

Inferred Ancestral Origin of Cancer Cell Lines Associates with Differential Drug Response

M. Garnett, M. Menden, Alexander J Ohnmacht, 2021, International journal of molecular sciences.

Can artificial intelligence accelerate preclinical drug discovery and precision medicine?

M. Menden, Alexander J Ohnmacht, A. Farnoud, 2022, Expert opinion on drug discovery.

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

M. Menden, J. Holch, Alexander J Ohnmacht, 2023, Nature communications.